Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Trace-Ability
AddedFeb 15, 2024
UpdatedJun 18, 2026
Trace-Ability

Trace-Ability

US-based Traceability manufactures radiopharmaceuticals and offers automated solutions for PET and SPECT radiotracer testing.

HQ
Culver City, CA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded in Culver City, United States, Trace-Ability focuses on manufacturing radiopharmaceuticals for positron-emission tomography (PET) and single-photon emission computed tomography (SPECT). Their core mission is to enhance the quality control of radiotracers through automation and innovation. The company offers products like the Tracer-QC™, an automated solution utilizing optical plate readers, pipetting robots, and single-use consumable kits for release testing of PET and SPECT radiotracers, ensuring optimal cGMP compliance.

Notable figures affiliated with Trace-Ability include their leadership team and a dedicated scientific advisory board. The company has achieved significant milestones in automating radiopharmaceutical quality control, contributing to more reliable and efficient testing processes. Their impact is evident in the improved accuracy and traceability of radiotracer testing, benefiting both the medical imaging industry and patient outcomes.

Trace-Ability - Similar Companies

BlueTrace logo

BlueTrace

oystertracker.com

Trace Matters logo

Trace Matters

tracematters.com

Trace Register logo

Trace Register

TrackX Technology logo

TrackX Technology

trackx.tech

Trace.Space logo

Trace.Space

trace.space

TraceRx logo

TraceRx

InfiniTrak logo

InfiniTrak

infinitrak.us

Tag-N-Trac logo

Tag-N-Trac

tagntrac.com

Trace Labs logo

Trace Labs

tracelabs.io

Tracer logo

Tracer

tracer.tech

Antares Vision logo

Antares Vision

antaresvision.com

Q-Track logo

Q-Track

q-track.com

121nexus logo

121nexus

121nexus.com

Traceable logo

Traceable

traceable.ai

TeleTracking Technologies logo

TeleTracking Technologies

teletracking.com

Trace-Ability - Quick Facts

Who are Trace-Ability's competitors?

Companies similar to Trace-Ability include BlueTrace, Trace Matters, Trace Register and TrackX Technology.

When was Trace-Ability founded?

Trace-Ability was founded in 2013.

Where is Trace-Ability's headquarters located?

Trace-Ability's headquarters is located in Culver City, CA, US.

When was Trace-Ability's last funding round?

Trace-Ability's most recent funding round was for $1.1M (USD) in February 2016.

How much has Trace-Ability raised to-date?

As of Feb 29, 2016, Trace-Ability has raised a total of $1.3M (USD).

How many employees does Trace-Ability have?

Trace-Ability has 6 employees as of Feb 4, 2024.

Trace-Ability - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Automation
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Quality Control
  • Radiopharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software